except for the active substance. For details see IMPD_Placebo clinical trials

Antisense Oligonucleotide Eye Drops against IRS-1 to Optimize Pretransplant Lymphangio-regression Prior to High-Risk Keratoplasty (Olisens-Precon)

This study is testing new eye drops called OLISENS for adults with specific eye damage before a high-risk cornea transplant. The aim is to reduce abnormal blood vessels in the eye, which may improve transplant success. It's a phase II trial to check safety and how well it works.